Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine > News > Integrated imaging opens the way for virtual biopsies
  • News

Integrated imaging opens the way for virtual biopsies

  • 15 January 2021
  • Janet Fricker
Illustration shows the accuracy of the CT/US fusion for pelvic tumours in ovarian cancer, where the dashed line shows the CT segmentation and the solid line shows US segmentation.
Source: Adapted from Fig.3, L Beer et al. (2020) Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer. Eur Radiol Republished under a Creative Commons Licence
Integrated imaging opens the way for virtual biopsies
Total
0
Shares
0
0
0
0
0

Combining computed tomography (CT) scans, spatial radiomic maps, and ultrasound (US) images creates a visual guide that helps doctors perform fewer and more accurate tumour biopsies. The feasibility study, published in European Radiology (14 December), demonstrates how imaging can be used to non-invasively unravel the heterogeneity of ovarian cancer tumours and guide targeted biopsies. The University of Cambridge investigators believe that their integrated imaging approach could ultimately open the way for ‘virtual biopsies’ sparing patients invasive procedures.

Patients with ovarian cancer undergo a number of biopsies to obtain cancer tissue to confirm diagnosis for chemotherapy treatment. Biopsies are also needed for molecular profiling to test whether patients have BRCA1 or BRCA2 mutations in their cancer tissue, indicating that PARP inhibitors may be more effective. “The challenge is to get a good biopsy containing enough tissue for both cancer diagnosis and molecular profiling of the tumour. Tumours are heterogenous and it would be really helpful to be able to target the biopsy to the regions of the tumour that are most important,” explains James Brenton, Professor of Ovarian Cancer Medicine at the University of Cambridge and the medical oncologist on the team who undertook the study.

The integrated medicine approach, pioneered by the CRUK Cambridge Advanced Cancer Imaging Programme team, combines patient data from multiple sources to facilitate biopsy. For the study, CT scans of the tumours were subjected to radiomics, an approach that mathematically extracts the signal intensities and pixel interrelationships of the image to provide quantitative descriptions. “Radiomics tells us how texture and intensity changes across the tumour, allowing us to define different spatial regions with the same characteristics,” explains Mireia Crispin-Ortuzar, the physicist on the team.

Each different heterogenous region, known as a habitat, can be given a different colour code allowing investigators to visualise a number of distinct biological regions. The timeline involves undertaking the CT scan, then radiomics being performed and finally superimposing the CT radiomics habitats on to the real-time ultrasound to provide landmarks for biopsy. “In reality only a limited number of biopsies can be taken. This integrated approach allows the team to choose the lesions to biopsy that will provide the most meaningful information,” explains Evis Sala, Professor of Oncological Imaging at the University of Cambridge, who is leading the programme.

In the single-centre study, the team used the integrated approach for the first time on six women with advanced ovarian cancer, who were due to undergo US-guided biopsies before starting neoadjuvant chemotherapy. The investigators successfully demonstrated the different habitats of tumours, displayed them in real time, used the information to inform the location of biopsies, and obtained high quality tissue samples that were sufficient for routine workup and genomic analysis.

For reliable habitat-guided tissue targeting, accurate spatial registration between the CT and US images (known as fusion accuracy) is a prerequisite. When the team compared the contours of the US and CT scans, they found that the fusion accuracy was high for larger pelvic tumours but lower for the smaller omental metastases. This, the authors, suggest, may be explained by the larger tumour volume of the pelvic lesions and their relatively fixed position in the pelvis compared to the more flexible and smaller omental deposits.
The team now plan to discover and validate radiogenomic biomarkers in patients with ovarian and kidney cancers.

“One of the reasons the technique is so exciting is that it allows us to sample tumour habitats in vivo. It means that we may be able to track whether therapies are working,” explains Sala. “Ultimately, if we have biological validation to show the patterns of different tumour mutations we may be able to avoid biopsies altogether.”

Commenting on the significance of the study, Iain McNeish, Director of the Ovarian Cancer Action Research Centre, Imperial College London, says, “Obtaining a high quality biopsy is essential in women with ovarian cancer. Not only does this ensure that an accurate diagnosis is made, it also means that there will be enough material to perform detailed molecular analyses that are increasingly important for directing patient care. This study will ensure that radiologists know exactly which area to target for biopsy, thus ensuring that patients are diagnosed as quickly and reliably as possible. Importantly, this work can be readily applied in routine patient care immediately.”

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • computed tomography
  • integrated approach
  • ovarian cancer
  • radiomics
  • tumour biopsy
  • ultrasound
Janet Fricker

Janet Fricker is a medical writer specialising in oncology and cardiology. After researching articles for Cancerworld she runs, swims, and eats porridge.

Previous Article
  • Articles
  • Medicine

Highlights of 2020 American Society of Hematology (ASH) meeting

  • 14 January 2021
  • Janet Fricker
View Post
Next Article
  • Articles
  • Delivery of Care

Berlin pilot project brings precision care to the peripheries

  • 15 January 2021
  • Simon Crompton
View Post
You May Also Like
View Post
  • News

Study highlights need to reanalyse genomics and genetics of metastatic tumours

  • Janet Fricker
  • 27 January 2023
View Post
  • News

Current cervical cancer screening paradigm fails older women

  • Janet Fricker
  • 26 January 2023
View Post
  • News

Call-to-arms for Europe to provide essential paediatric anti-cancer medicines

  • Janet Fricker
  • 9 January 2023
View Post
  • News

Exercise-stimulated myokine production can extend survival in advanced prostate cancer

  • Janet Fricker
  • 9 January 2023
View Post
  • News

Five San Antonio take-aways to improve care of breast cancer patients

  • Janet Fricker
  • 16 December 2022
View Post
  • News

Repurposed drug combination reduces risk of recurrence following surgery for colorectal cancer

  • Janet Fricker
  • 16 December 2022
View Post
  • News

Aerobic activity to outcompete metastasis 

  • Janet Fricker
  • 2 December 2022
View Post
  • News

Ending cancer inequalities: European summit showcases new tools to inform policy

  • Anna Wagstaff
  • 30 November 2022

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Study highlights need to reanalyse genomics and genetics of metastatic tumours
    • 27 January 2023
  • Current cervical cancer screening paradigm fails older women
    • 26 January 2023
  • Call-to-arms for Europe to provide essential paediatric anti-cancer medicines
    • 9 January 2023
  • Exercise-stimulated myokine production can extend survival in advanced prostate cancer
    • 9 January 2023
  • Five San Antonio take-aways to improve care of breast cancer patients
    • 16 December 2022
Article
  • The cancer patients still struggling to access drugs in the wake of anti-corruption reforms
    • 27 January 2023
  • Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access
    • 26 January 2023
  • Cervical cancer elimination efforts boosted by simpler ways to identify and treat pre-cancerous lesions
    • 12 January 2023
Latest printed issue
Social

Would you follow us ?

Contents
  • AI in Genomics and Reporting for Clinical Practice
    • 26 January 2023
  • Telemedicine in Cancer Care: Monitoring, Follow-Up,Tele-Rehabilitation, Palliative and Supportive Care
    • 23 January 2023
  • AI application in diagnosis
    • 11 January 2023
MENU
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine
  • About the Magazine
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is funded by SPCC Sharing Progress in Cancer Care | Via Vincenzo Vela 6, 6500 Bellinzona - Switzerland | info@spcc.net

Archivio Cancerworld

Input your search keywords and press Enter.